(0.31%) 5 115.98 points
(0.32%) 38 360 points
(0.34%) 15 982 points
(-0.94%) $83.06
(5.51%) $2.03
(0.36%) $2 355.60
(0.42%) $27.65
(4.01%) $959.10
(-0.24%) $0.932
(-0.39%) $10.98
(-0.56%) $0.796
(1.69%) $93.43
@ $5.15
発行日: 15 2月 2024 @ 01:02
リターン: 51.94%
前回のシグナル: 2月 14 - 23:30
前回のシグナル:
リターン: -1.81 %
Live Chart Being Loaded With Signals
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally...
Stats | |
---|---|
本日の出来高 | 436 396 |
平均出来高 | 2.78M |
時価総額 | 1.04B |
EPS | $0 ( 2024-02-22 ) |
次の収益日 | ( $-0.0300 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -8.69 |
ATR14 | $0.0110 (0.14%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Burch Andrew | Sell | 16 758 | Class A Common Stock |
2024-03-15 | Buzzeo Rebecca | Sell | 4 366 | Class A Common Stock |
2024-03-15 | Oreshack Kurt | Sell | 4 551 | Class A Common Stock |
2024-03-15 | Dolan Christine | Sell | 5 383 | Class A Common Stock |
2024-03-15 | Leddy Peter Michael | Sell | 6 714 | Class A Common Stock |
INSIDER POWER |
---|
22.90 |
Last 97 transactions |
Buy: 5 599 282 | Sell: 7 496 137 |
ボリューム 相関
Maravai LifeSciences 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Maravai LifeSciences 相関 - 通貨/商品
Maravai LifeSciences 財務諸表
Annual | 2023 |
収益: | $288.95M |
総利益: | $137.60M (47.62 %) |
EPS: | $-0.900 |
FY | 2023 |
収益: | $288.95M |
総利益: | $137.60M (47.62 %) |
EPS: | $-0.900 |
FY | 2022 |
収益: | $883.00M |
総利益: | $714.04M (80.87 %) |
EPS: | $3.73 |
FY | 2021 |
収益: | $799.24M |
総利益: | $658.68M (82.41 %) |
EPS: | $1.590 |
Financial Reports:
No articles found.
Maravai LifeSciences
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。